Gastric emptying and symptoms of bulimia nervosa: Effect of a prokinetic agent

Physiology and Behavior

Volumn 106, Issue 2, 2012, Pages 238-242

  Devlin, Michael J ^a   Kissileff, Harry R ^b   Zimmerli, Ellen J ^a   Samuels, Francine ^a   Chen, Benny E ^a   Brown, Amanda J ^a   Geliebter, Allan ^b   Walsh, B Timothy ^a  

^a Columbia University ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Bulimia nervosa; Cholecystokinin; Eating disorders; Eating laboratory; Gastric emptying; Pharmacotherapy

Indexed keywords

CHOLECYSTOKININ; ERYTHROMYCIN; GHRELIN; PEPTIDE YY;

ADULT; ARTICLE; BINGE EATING DISORDER; BULIMIA; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; VOMITING;

ADOLESCENT; ADULT; BULIMIA NERVOSA; CHOLECYSTOKININ; DOUBLE-BLIND METHOD; ERYTHROMYCIN; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL AGENTS; GHRELIN; HUMANS; MIDDLE AGED; MOTILIN; PEPTIDE YY;

EID: 84862828922     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2012.02.009     Document Type: Article

References (28)

1. Kissileff H.R., Wentzlaff T.H., Guss J.L., Walsh B.T., Devlin M.J., Thornton J.C. A direct measure of satiety disturbance in patients with bulimia nervosa. Physiol Behav 1996, 60:1077-1085.
2. Prince A.C., Brooks S.J., Stahl D., Treasure J. Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. Am J Clin Nutr 2009, 89:755-765.
3. Geliebter A., Melton P.M., McCray R.S., Gallagher D.R., Gage D., Hashim S.A. Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. Am J Clin Nutr 1992, 56:656-661.
4. Devlin M.J., Walsh B.T., Guss J.O., Kissileff H.R., Liddle R.A., Petkova E. Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr 1997, 56:114-120.
5. Walsh B.T., Zimmerli E., Devlin M.J., Guss J., Kissileff H.R. A disturbance of gastric function in bulimia nervosa. Biol Psychiatry 2003, 54:929-933.
6. Geliebter A., Hashim S.A. Gastric capacity in normal, obese, and bulimic women. Physiol Behav 2001, 74:743-746.
7. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, 589-594. American Psychiatric Association, Washington, DC, (Text Revision). 4th ed.
8. Szmukler G.I., Young G.P., Miller G., Lichtenstein M., Binns D.S. A controlled trial of cisapride in anorexia nervosa. Int J Eat Disord 1995, 17:347-357.
9. Gumaste V., Baum J. Treatment of gastroparesis: an update. Digestion 2008, 173-179.
10. Wysowski D.K., Corken A., Gallo-Torres H., Talarico L., Rodriguez E.M. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions. Am J Gastroenterol 2001, 96:1698-1703.
11. Kojima S., Nakahara T., Nagai N., Muranaga T., Tanaka M., Yasuhara D., et al. Altered ghrelin and peptide YY responses to meals in bulimia nervosa. Clin Endocrinol (Oxf) 2005, 62:74-78.
12. Monteleone P., Martiadis V., Rigamonti A.E., Fabrazzo M., Giordani C., Muller E.E., et al. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa. Biol Psychiatry 2005, 57:926-931.
13. Fairburn C.G., Cooper Z. The Eating Disorder Examination. Binge eating: nature, assessment, and treatment 1993, 317-360. The Guilford Press, New York. 12th Edition. C.G. Fairburn, G.T. Wilson (Eds.).
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured clinical interview for DSM-IV axis I disorders (SCID) 1995, New York State Psychiatric Institute, Biometrics Research, New York.
15. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
16. Stunkard A.J., Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985, 29:71-83.
17. Rehfield J.F. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul Pept 1998, 78:31-39.
18. Zimmerli E.J., Walsh B.T., Guss J.L., Devlin M.J., Kissileff H.R. Gastric compliance in bulimia nervosa. Physiol Behav 2006, 87:441-446.
19. Geliebter A. Gastric distension and gastric capacity in relation to food intake in humans. Physiol Behav 1988, 44:685-688.
20. Muurahainen N., Kissileff H.R., Derogatis A.J., Pi-Sunyer F.X. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man. Physiol Behav 1988, 44:645-649.
21. Kissileff H.R., Carretta J.C., Geliebter A., Pi-Sunyer F.X. Cholecystokinin and stomach distension combine to reduce food intake in humans. Am J Physiol Regul Integr Comp Physiol 2003, 285:R992-R998.
22. Zimmerli E.J., Devlin M.J., Kissileff H.R., Walsh B.T. The development of satiety in bulimia nervosa. Physiol Behav 2010, 100:346-349.
23. Geracioti T.D., Liddle R.A. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med 1988, 319:683-688.
24. Keel P.K., Wolfe B.E., Liddle Ra, De Young K.P., Jimerson D.C. Clinical features and physiological response to a test meal in purging disorder and bulimia nervosa. Arch Gen Psychiatry 2007, 64:1058-1066.
25. Phillip E., Pirke K.M., Kellner M.B., Krieg J.C. Disturbed cholecystokinin secretion in patients with eating disorders. Life Sci 1991, 48:2443-2450.
26. Fujimoto S., Inui A., Kiyota N., Seki W., Koide K., Takamiya S., et al. Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa. Biol Psychiatry 1997, 41:1068-1070.
27. Hoecker M., Schmidt W.E., Cruetzfeldt W., Choudhury A.R., Nustede R., Schafmayer A., et al. Determination of plasma cholecystokinin (CCK) concentrations by bioassay and radioimmunoassay in man. A critical evaluation. Regul Pept 1992, 37:255-269.
28. Hoecker M., Schmidt W.E., Wilms H.M., Lenhoff F., Nustede R., Schafmayer A., et al. Measurement of tissue cholecystokinin (CCK) concentrations by bioassay and specific radioimmunoassay: characteristics of the bioactivity of CCK-58 before and after tryptic cleavage. Eur J Clin Invest 1990, 20(Suppl. 1):S45-S50.